High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$339K
$339,012
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ANAB
S
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Sell to Cover
2026-01-08
$163,192
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-08 | $163,192 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Equity Compensation
2026-01-07
$0
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Sell to Cover
2026-01-07
$100,821
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-07 | $100,821 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Equity Compensation
2026-01-06
$0
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Equity Compensation
2025-12-22
$27,750x2
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-22 | $27,750x2 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-22
$75,000
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-22 | $75,000 | S | Form 4 |